In vitro evaluation of cefixime (FK027, FR17027, CL284635): Spectrum against recent clinical isolates, comparative antimicrobial activity, β-lactamase stability, and preliminary susceptibility testing criteria
- 31 July 1986
- journal article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 5 (2), 151-162
- https://doi.org/10.1016/0732-8893(86)90117-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniquesAntimicrobial Agents and Chemotherapy, 1984
- Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporinAntimicrobial Agents and Chemotherapy, 1984
- Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factorsAntimicrobial Agents and Chemotherapy, 1983
- Cefmenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive CriteriaAntimicrobial Agents and Chemotherapy, 1981
- Method of reliable determination of minimal lethal antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1980
- Cefroxadine (CGP-9000), an orally active cephalosporinAntimicrobial Agents and Chemotherapy, 1980
- Cefaclor: In Vitro Spectrum of Activity and Beta-Lactamase StabilityAntimicrobial Agents and Chemotherapy, 1978
- Comparison of In Vitro Activity of Cephalexin, Cephradine, and CefaclorAntimicrobial Agents and Chemotherapy, 1977
- Cefadroxil, a New Broad-Spectrum CephalosporinAntimicrobial Agents and Chemotherapy, 1977
- BL-S 640, a Cephalosporin with a Broad Spectrum of Antibacterial Activity: Properties In VitroAntimicrobial Agents and Chemotherapy, 1975